Page last updated: 2024-09-05

24-norursodeoxycholic acid and cenicriviroc

24-norursodeoxycholic acid has been researched along with cenicriviroc in 1 studies

Compound Research Comparison

Studies
(24-norursodeoxycholic acid)
Trials
(24-norursodeoxycholic acid)
Recent Studies (post-2010)
(24-norursodeoxycholic acid)
Studies
(cenicriviroc)
Trials
(cenicriviroc)
Recent Studies (post-2010) (cenicriviroc)
35227521246

Protein Interaction Comparison

ProteinTaxonomy24-norursodeoxycholic acid (IC50)cenicriviroc (IC50)
C-C chemokine receptor type 7Homo sapiens (human)0.0031
C-C chemokine receptor type 2Homo sapiens (human)0.0059
C-C chemokine receptor type 5Homo sapiens (human)0.003
C-C chemokine receptor type 5Mus musculus (house mouse)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, HX; Liang, ZY; Qin, SY; Su, SB; Wang, F; Yan, YD; Zhangdi, HJ1

Reviews

1 review(s) available for 24-norursodeoxycholic acid and cenicriviroc

ArticleYear
Crosstalk network among multiple inflammatory mediators in liver fibrosis.
    World journal of gastroenterology, 2019, Sep-07, Volume: 25, Issue:33

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Hepatic Stellate Cells; Hepatocytes; Humans; Imidazoles; Inflammation; Inflammation Mediators; Liver; Liver Cirrhosis; Molecular Targeted Therapy; Protein Kinase Inhibitors; Pyrimidinones; Signal Transduction; Sulfoxides; Ursodeoxycholic Acid

2019